Industry | 2009.11.30
Covidien Completes Sale of Oxygen Therapy Product Line
DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it had completed the previously announced sale of its Oxygen Therapy assets to Chart Industries, Inc. (NASDAQ: GTLS). Financial terms of the transaction were not disclosed. The sale of the Oxygen Therapy product line, which includes products sold under the Companion™ and Helios™ brands, was made following a thorough review and evaluation of a number of strategic alter
For more information, please visit
http://www.businesswire.com/news/home/20091130005237/en
